Position in NKTR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,234,033
+$1,132,778 QoQ
Shares Held
89,300
+26.0% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
4.07%
of 13F equity value
Holder Rank
#60
of 239 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACT CAPITAL MANAGEMENT, LLC holds $97,112,758 across 27 Biotechnology names. NKTR ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
45,000 | $16,725,150 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
251,025 | $13,791,313 | |
| 3 | ABVX |
Abivax S.A.
|
97,000 | $12,926,220 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
110,100 | $8,974,251 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
209,300 | $8,164,793 | |
| 6 | CELC |
Celcuity Inc.
|
62,150 | $6,502,133 | |
| 7 | NKTR |
Nektar Therapeutics
This page
|
89,300 | $6,234,033 | |
| 8 | CYTK |
Cytokinetics Inc
|
47,500 | $4,046,525 |
All Filings in NKTR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,234,033 | 89,300 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,101,255 | 70,900 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,164,736 | 51,200 | Shares | Sole | 2026-02-17 | |
| 2022-03-31 | $32,340 | 6,000 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $621,460 | 46,000 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,900,540 | 161,500 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,771,340 | 161,500 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||